Financials

News Ideas Technicals Forecast

SONN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Sonnet BioTherapeutics Holdings, Inc.

Total assets of SONN for Q1 24 is 5.34 M USD, 1.69% less than the previous Q4 23. And total liabilities decreased by 51.10% in Q1 24 to 2.77 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—